Loading...
Market
Will Eli Lilly and OpenAI identify a novel antimicrobial drug candidate by March 31, 2024?
5
Resolution / Starting Odds
Yes, identified and announced • 33%
Yes, identified but not announced • 33%
No, not identified • 33%
Official press release from Eli Lilly or scientific publication
Story
Eli Lilly Collaborates with OpenAI to Combat Drug-Resistant Bacteria
Jun 25, 2024, 02:02 PM
Eli Lilly has announced a collaboration with OpenAI to discover novel medicines targeting drug-resistant bacteria. The partnership will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobials aimed at treating drug-resistant pathogens. This initiative marks a significant step in the fight against drug-resistant bacteria, which pose a growing threat to global health.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
